| Mrs Thelisa Y Sulton, | |
|
201 Columbia Mall Blvd Ste 189, Columbia, SC 29223-7550 | |
| (803) 602-5570 | |
| (888) 958-0279 |
| Full Name | Mrs Thelisa Y Sulton |
|---|---|
| Gender | Female |
| Speciality | Technician/technologist |
| Location | 201 Columbia Mall Blvd Ste 189, Columbia, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851888978 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Thelisa Y Sulton, 201 Columbia Mall Blvd Ste 189, Columbia, SC 29223-7550 Ph: (803) 602-5570 | Mrs Thelisa Y Sulton, 201 Columbia Mall Blvd Ste 189, Columbia, SC 29223-7550 Ph: (803) 602-5570 |
News Archive
Biocept, Inc., a molecular diagnostics company commercializing and developing liquid biopsies to improve the diagnosis and treatment of cancer, announces that the European Patent Office has awarded the patent, "DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS," as announced in the European Bulletin dated November 11, 2015.
Just like teenagers at a prom, proteins are tended by chaperones whose job it is to prevent unwanted interactions among immature clients. And at the molecular level, just as at the high school gym level, it's a job that usually requires a lot of energy.
American Society of Anesthesiologists (ASA) Global Humanitarian Outreach (GHO) volunteer Megan Olejniczak, M.D., will travel to Rwanda on Monday, October 19, to participate in a teaching program at the two teaching hospitals of the National University of Rwanda in the cities of Kigali and Butare.
An optical fiber probe can distinguish cancer tissue and normal tissue at the margins of a tumor being excised, in real time, by detecting the difference in pH between the two types of tissue.
A team of UK scientists has made the unexpected discovery that drugs which target a well known fault in a protein called BRAF could actually fuel the progression of cancer in some cases. The findings of this study, which was jointly funded by Cancer Research UK, The Institute of Cancer Research (ICR) and the Wellcome Trust are published in Cell.
› Verified 3 days ago